Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Gastro-enteropancreatic neuroendocrine tumor 2Pheochromocytoma 1Paraganglioma 1Oncogenic osteomalacia 1Metastatic Neuroendocrine Prostate Cancer 1Meningioma 1Kidney Neoplasms 1Head and Neck Neoplasms 1Carcinoma, Medullary 1Carcinoid Tumor 1

Interventions

Magnetic Resonance Spectroscopy 4Temozolomide 3Surgical Procedures, Operative 3trametinib 2Magnetic Resonance Imaging 2Irinotecan 2Bortezomib 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2temsirolimus 1sonidegib 1ribociclib 1gallium Ga 68 dotatate 1fluoromisonidazole 1entinostat 1emvododstat 1carboxyamido-triazole 1avelumab 1aldesleukin 1Vorinostat 1Verteporfin 1Topotecan 1Thalidomide 1Surveys and Questionnaires 1Sodium Chloride 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiosurgery 1Proton Therapy 1Pioglitazone 1Photochemotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Meningioma × gallium Ga 68 dotatate × Clear all
NCT03953131 2023-09-01

Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas

M.D. Anderson Cancer Center

Phase 1 Completed
13 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡